Cardio Diagnostics Holdings, Inc. Operating Lease, Payments
Cardio Diagnostics Holdings, Inc. (CDIO) reported Operating Lease, Payments of $131.22 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-08-07
- Cardio Diagnostics Holdings, Inc. operating lease, payments for the quarter ending 2026-06-30 was $65.61K, a 1.21% increase year-over-year.
- Cardio Diagnostics Holdings, Inc. operating lease, payments for the quarter ending 2026-03-31 was $65.61K, a 1.21% increase year-over-year.
- Cardio Diagnostics Holdings, Inc. operating lease, payments for the quarter ending 2025-12-31 was $65.61K, a 1.21% increase year-over-year.
- Cardio Diagnostics Holdings, Inc. operating lease, payments for the quarter ending 2025-09-30 was $65.35K, a 1.21% increase year-over-year.
- Cardio Diagnostics Holdings, Inc. operating lease, payments for fiscal 2025 was $260.61K, a 1.21% increase from fiscal 2024.
- Cardio Diagnostics Holdings, Inc. operating lease, payments for fiscal 2024 was $257.51K, a 1106.01% increase from fiscal 2023.
- Cardio Diagnostics Holdings, Inc. operating lease, payments for fiscal 2023 was $21.35K.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $65.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $131.22K 10-Q · filed 2026-08-07 | $196.83K derived: sum of 3 quarters · filed 2026-08-07 | $262.18K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $65.61K 10-Q · filed 2026-05-15 | $131.22K derived: sum of 2 quarters · filed 2026-05-15 | $196.57K derived: sum of 3 quarters · filed 2026-05-15 | $261.39K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $65.61K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $130.96K derived: sum of 2 quarters · filed 2026-03-13 | $195.78K derived: sum of 3 quarters · filed 2026-08-07 | $260.61K 10-K · filed 2026-03-13 |
| 2025-09-30 | $65.35K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $130.18K derived: sum of 2 quarters · filed 2026-08-07 | $195.00K 10-Q · filed 2025-11-12 | $259.83K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $64.83K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $129.65K 10-Q · filed 2026-08-07 | $194.48K derived: sum of 3 quarters · filed 2026-08-07 | $259.05K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $64.83K 10-Q · filed 2026-05-15 | $129.65K derived: sum of 2 quarters · filed 2026-05-15 | $194.22K derived: sum of 3 quarters · filed 2026-05-15 | $258.28K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $64.83K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $129.40K derived: sum of 2 quarters · filed 2026-03-13 | $193.45K derived: sum of 3 quarters · filed 2026-03-13 | $257.51K 10-K · filed 2026-03-13 |
| 2024-09-30 | $64.57K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $128.63K derived: sum of 2 quarters · filed 2025-11-12 | $192.68K 10-Q · filed 2025-11-12 | $192.68K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $64.06K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $128.11K 10-Q · filed 2025-08-14 | $128.11K derived: sum of 3 quarters · filed 2025-08-14 | |
| 2024-03-31 | $64.06K 10-Q · filed 2025-05-15 | $64.06K derived: sum of 2 quarters · filed 2025-05-15 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $21.35K 10-K · filed 2025-03-20 | ||
| 2023-09-30 | $21.35K 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |